Hospital-Acquired Infection Diagnostics Market Growing Opportunity with Latest Trends

The HAI diagnostics market size is projected to cross $4.3 billion by 2023, growing at a CAGR of 7.6% between 2017-2023.
The growth in the market will be led by the increase in incidences of infections caused in clinical settings, especially in developing economies owing to their poor hygiene facilities.

In terms of product, the HAI diagnostics market is segmented into reagents & consumables and instruments. The reagents & consumables occupied the larger share in the market in 2016 and are expected to maintain the same trend throughout the forecast period. This is attributable to specificity of the reagents providing the accurate results with the target substance in the sample. In medical laboratories, reagents play an important role in diagnostic testing assays of infectious diseases.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market/report-sample

The European HAI diagnostics market is projected to grow at a steady pace during 2017-2023, to cross $1.2 billion by 2023. According to the International Trade Administration (ITA), there is growth in the market, with the major companies such as Roche Diagnostics Limited, Abbott Laboratories, and others investing more in the R&D of the innovative diagnostics products to remain competitive in this field. Along with it, the growth of the hospital acquired diagnostics market in Europe is also characterized by the increase in geriatric population and high incidence of hospital acquired infections.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hospital-acquired-infection-diagnostics-market

Technologically advanced products aid by offering accurate and reliable results with low turnaround time. Major companies in the HAI diagnostics market are investing in the development of the molecular diagnostics, looking forward to the growth and demand in the field. For instance, Roche diagnostics, in 2017, launched cobas Liat PCR system with four assays, which also include 20-minute real-time PCR nucleic acid test to detect Clostridium difficile. The company also launched cobas HPV for using on cobas 6800/8800 system for cervical cancer screening, 2017. Cobas 6800/8800 system is a two integrated and fully automated molecular testing system for blood and plasma donor screening. Qiagen N.V., in 2017, launched ipsogen JAK2 RGQ PCR Kit for detection of blood cancer, ipsogen portfolios common, and rare leukemia types.

Some of the key players operating in the HAI diagnostics market are Abbott Laboratories, AstraZeneca plc, Bayer AG, Daiichi Sankyo Co. Ltd., Danaher Corporation, Hologic Inc., Johnson & Johnson, OpGen Inc., and F. Hoffmann-La Roche AG.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Point-of-Care Ultraosund Device Market Outlook, Key Trends, and Demand

The global point-of-care (PoCUS) device market is expected to grow at a CAGR of 6.9% during 2015 - 2025. The growth of the global market is largely driven by increasing awareness about the benefits of portable ultrasound devices in point-of-care.

Several beneficial features such as size, weight, performance and battery life of portable ultrasound devices are increasing their popularity among healthcare providers. Healthcare providers and patients are getting aware about these benefits of portable ultrasound devices in point-of-care. This has created huge traction in the diagnostic imaging industry for developing portable ultrasound devices for point-of-care. Different companies are investing huge capital for miniaturization of ultrasound devices for their efficient use in point-of-care. Some of the other factors driving the growth of the global market include prevalence of chronic diseases, and technological advancements. Increasing penetration of PoCUS device manufacturers in emerging economies is expected to create ample growth opportunities for the global market. However, lack of skilled sonographers and stringent regulatory requirements are the key barriers for the growth of the global market.

Europe accounted for the largest share in the global market in 2015 due to the technological advancements and high compliance for portable ultrasound devices in point-of-care. The U.S., Japan and Germany were the top three market for PoCUS devices in 2015. The U.S. contributed largest revenue to global PoCUS device market. The country is expected to remain the largest market for PoCUS devices globally during the forecast period. The huge capital investments along with the significant development for portable ultrasound devices in point-of-care are the key driving factors of the U.S. PoCUS device market.

Request for a sample of this research report: https://www.psmarketresearch.com/market-analysis/pocus-device-market/report-sample


Among the different applications, the largest revenue was generated from the sale of PoCUS devices point-of-care cardiology in 2015. The non-invasive characteristics of PoCUS, high incidence of cardiac diseases, growing geriatric population and increasing demand from home care and ambulatory settings are the key driving factors for the application segment.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=pocus-device-market


Some of the players operating in the global market include Hitachi Ltd., Toshiba Medical Systems Corporation, Siemens AG, Koninklijke Philips N.V., Esaote SpA, General Electric Company, Samsung, Mindray Medical International Limited, FUJIFILM Holdings Corporation, and Analogic Corporation.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Home-Use Beauty Devices Market Trade Analysis, Investment Feasibility, And Outlook by 2023

Global home-use beauty devices market is expected to reach $16.7 billion by 2023, according to P&S Market Research.
The market is mainly driven by increasing inclination of consumers toward easy-to-use home-use beauty devices, rising prevalence of skin diseases, growing appearance consciousness in people and awareness about these devices, expanding product portfolio of market players, and surge in disposable income.


Based on type, the home-use beauty devices market for anti-aging is expected to reach $3.9 billion by 2023, registering a CAGR of 21.7% during the forecast period. As stated by the United Nations (U.N.), in 2017, there are around 962 million people aged 60 or above, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% every year. Thus, various beauty-related problems associated with aging, such as wrinkles, loosening of the skin, increase in facial hair, and drooping eyebrows and eyelids, are contributing to the market growth of this category.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/home-use-beauty-devices-market/report-sample

The prevalence of androgenetic alopecia (hair loss) is reportedly higher in the European population as compared to the Asians, Native Americans, and African-Americans. The introduction of specialized hair regrowth devices in Europe has witnessed increased adoption by people, as problems such as hair loss are more common among Europeans as compared to the people in other regions. Besides, France is considered the fashion-hub of the world and is home to some of the renowned fashion brands. L’Oreal SA is one such brand based in France that commercializes cosmetics and home-use beauty devices.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=home-use-beauty-devices-market

Furthermore, in March 2018, the company completed its previously announced acquisition of ModiFace Inc., a provider of augmented reality and artificial intelligence in the beauty industry. The acquisition is in line with L'Oréal's digital acceleration strategy to integrate these technologies in its 34 international brands in order to enhance customer experience with the brand.

Some of the other key players operating in the home-use beauty devices market are Nu Skin Enterprises Inc., TRIA Beauty Inc., Home Skinovations Ltd., The Procter & Gamble Company, iluminage Beauty Inc., Koninklijke Philips N.V., Spectrum Brands Holdings Inc., YA-MAN LTD., MTG Co. Ltd., and Carol Cole Company.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Respiratory Care Device Market Comprehensive Review of its Applications and Growth Opportunities

The respiratory care device market was valued at $15.0 billion in 2015 and is expected to grow at a CAGR of 8.1% between 2016-2022.

The technological advancement in respiratory monitoring and diagnosis devices, increasing prevalence of respiratory diseases, growing geriatric population and high prevalence of tobacco smoking are the key factors driving the growth of the market.

Among the different end users of the respiratory care device market, the home care market would witness fastest growth during the forecast period. Growing geriatric population and increasing demand for home care are the major factors driving the growth of the respiratory care device in home care market.

Request for a sample of this research report: https://www.psmarketresearch.com/market-analysis/respiratory-care-devices-market/report-sample

North America accounted for the largest share in the global respiratory care device market in 2015 and it is expected to grow at the considerable rate during the forecast period. The factors driving the market in the region are growing geriatric population, increasing prevalence of respiratory disease, and high adoption of technologically advanced respiratory diagnostic and monitoring devices. Europe was the second largest market for respiratory care device in 2015. The European market is primarily driven by rapid urbanization, technological advancement of devices, increasing prevalence of respiratory diseases, increasing healthcare expenditure, and high pollution level.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=respiratory-care-devices-market


Competitive Analysis
Some of the major players operating in the respiratory care device market include ResMed, Inc, General Electric Company, Hamilton Medical AG, Koninklijke Philips N.V, Masimo Corporation, and Medtronic plc.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Needle-Free Diabetes Management Market - its Top Companies, and Growth Opportunities

The needle-free diabetes management market size is set to cross $16.8 billion by 2025, growing at a CAGR of 17.8% between 2017-2025.

The market is driven by factors such as growing geriatric population, high prevalence of diabetes, technological advancements and increasing awareness regarding the safety issues associated with needles.

The needle-free diabetes management market comprises of treatment device, diagnostic device and artificial pancreas. In 2016, the treatment device led the market, whereas artificial pancreas is expected to grow at the fastest rate during the forecast period. In terms of type, needle-free diabetes treatment device market has been segmented into insulin pen and jet injectors, insulin patch and pump, and insulin inhalers. The needle-free insulin pen & jet injectors contributed the largest revenue in the global market during 2016, owing to the increasing compliance for jet injectors for diabetes treatment and improving dosing rate through jet injectors.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/needle-free-diabetes-management-market/report-sample

Asia-Pacific is the fastest growing region in the needle-free diabetes management market. The prevalence of Type 2 diabetes is increasing rapidly in Asia, which is the key growth driver for the needle-free diabetes management industry in the region. China is expected to have highest prevalence rate followed by India, due to increase in industrialization, urbanization and westernization. Another key factor creating huge demand for needle free diabetes management is the large geriatric patient pool. Older people are more diabetic prevalent; therefore, it significantly drives the Asia-Pacific needle-free diabetes management industry.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=needle-free-diabetes-management-market

The companies in the needle-free diabetes management market are collaborating with other firms to improve their position in the market. For instance, in October 2016, Pharmajet, Inc., collaborated with Vaccibody AS to provide technology for needle-free injection, which would help in the research for vaccines to treat HPV disease, known to be the main cause of cervical cancer.

Some of the key players in the needle-free diabetes management market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.